+30.4%
GSK vs CCEP
+24.3%
+6.1%
-18.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CCEP | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.9% | -3.1% | +1.2% | -0.9% |
| 7D | -1.8% | -3.1% | +1.2% | -0.8% |
| 30D | -2.2% | -2.6% | +0.4% | -1.3% |
| 3M | -1.8% | +14.9% | -16.7% | -7.1% |
| 6M | -10.6% | +2.3% | -12.9% | -11.8% |
| YTD | +4.4% | +17.8% | -13.4% | +1.2% |
| 1Y | +30.4% | +24.2% | +6.2% | +22.2% |
| All | +30.4% | +24.3% | +6.1% | +22.2% |
Cumulative growth
Daily Returns
Daily percentage return beside CCEP.
Daily Out/Under-Performance
Portfolio return minus CCEP return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CCEP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CCEP wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling